D
Inhibikase Therapeutics, Inc. IKT
$1.84 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments 1,004.10% 855.75% 636.06% -80.73% -62.07%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 98.37% 9.79% 8.43% -26.15% -36.11%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 42.23% -66.65% -51.64% 85.32% -26.41%
Total Current Assets 932.16% 771.27% 592.78% -76.13% -60.87%

Total Current Assets 932.16% 771.27% 592.78% -76.13% -60.87%
Net Property, Plant & Equipment -73.84% -55.21% -49.76% -43.39% -38.39%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 906.63% 751.83% 579.69% -75.52% -60.50%

Total Accounts Payable 101.69% 30.79% 45.79% 244.30% 77.76%
Total Accrued Expenses 54.63% 40.10% 18.58% 16.32% 11.12%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -75.10% -50.53% -26.38% -2.55% 2.84%
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 137.54% 102.00% 8.58% 78.99% 35.55%

Total Current Liabilities 137.54% 102.00% 8.58% 78.99% 35.55%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- -82.93%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 135.91% 99.25% 5.81% 71.42% 29.38%

Common Stock & APIC 142.71% 147.46% 143.10% 5.16% 5.17%
Retained Earnings -54.25% -51.08% -41.14% -31.19% -31.62%
Treasury Stock & Other -190.00% 44.44% -4,233.33% 1,900.00% 41.18%
Total Common Equity 1,470.73% 1,165.08% 764.16% -103.53% -73.82%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 1,470.73% 1,165.08% 764.16% -103.53% -73.82%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 1,470.73% 1,165.08% 764.16% -103.53% -73.82%